{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:28:17Z","timestamp":1791109697292,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.jaci.2009.10.030","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T04:18:36Z","timestamp":1265343516000},"page":"703-710.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["CD94\/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis"],"prefix":"10.1016","volume":"125","author":[{"given":"Esther","family":"Morel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Escamochero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Caba\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fiandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2009.10.030_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jaci.2009.10.030_bib2","series-title":"Drug hypersensitivity","first-page":"267","article-title":"Clinic and pathogenesis of severe bullous skin reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis","author":"Allanore","year":"2007"},{"key":"10.1016\/j.jaci.2009.10.030_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2009.10.030_bib4","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.10.030_bib5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4049\/jimmunol.164.3.1148","article-title":"Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression","volume":"164","author":"Pittet","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib7","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C","article-title":"The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha\/beta-mediated recognition","volume":"31","author":"Pietra","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-2478(03)00074-9","article-title":"Cellular and molecular basis of natural killer and natural killer-like activity","volume":"88","author":"Moretta","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2009.10.030_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2009.10.030_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0198-8859(99)00161-5","article-title":"Paired inhibitory and triggering NK cell receptors for HLA class I molecules","volume":"61","author":"L\u00f3pez-Botet","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20060028","article-title":"Reprogramming of CTLs into natural killer-like cells in celiac disease","volume":"203","author":"Meresse","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2009.10.030_bib12","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/eji.200425843","article-title":"The CD94\/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells","volume":"35","author":"Gum\u00e1","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2009.10.030_bib14","series-title":"Cell growth and division. A practical approach","first-page":"81","article-title":"Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells","author":"Rheinwald","year":"1989"},{"key":"10.1016\/j.jaci.2009.10.030_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.1993.01680250078010","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2009.10.030_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000051751","article-title":"CD8+ lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: further similarities with toxic epidermal necrolysis","volume":"203","author":"Correia","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2009.10.030_bib17","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.160.10.4951","article-title":"HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences","volume":"160","author":"Lee","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib18","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2009.10.030_bib19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO;2-M","article-title":"Human T cell receptor-mediated recognition of HLA-E","volume":"32","author":"Garc\u00eda","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2009.10.030_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1051\/medsci\/2006222188","article-title":"[Epidermal necrolysis: mechanisms of keratinocyte apoptosis]","volume":"22","author":"Roujeau","year":"2006","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.jaci.2009.10.030_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2009.10.030_bib23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2009.10.030_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib25","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2009.10.030_bib26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib27","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.1073\/pnas.93.22.12433","article-title":"Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations","volume":"93","author":"Mingari","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2009.10.030_bib28","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1002\/eji.200425210","article-title":"Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes","volume":"34","author":"Arlettaz","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib29","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2009.10.030_bib30","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.177.5.3100","article-title":"Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells","volume":"177","author":"Derre","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.10.030_bib31","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1182\/blood-2006-06-030213","article-title":"Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation","volume":"109","author":"Coupel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2009.10.030_bib32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2009.10.030_bib33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/01.aids.0000183632.12418.33","article-title":"Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy","volume":"19","author":"Mela","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2009.10.030_bib34","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/eji.200535343","article-title":"Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion","volume":"35","author":"Mazzarino","year":"2005","journal-title":"Eur J Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909015668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909015668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:20:50Z","timestamp":1758788450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674909015668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0091674909015668"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2009.10.030","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD94\/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2009.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}